SCHEMBL8287403

SCHEMBL8287403

Cc1cc2c(c(N3CCOCC3)n1)c(=O)cc(Nc1ccccc1)n2-c1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE11A Q9HCR9 1/20 0.56
IGF1R P08069 1/20 0.47
MAPT P10636 4/20 0.43
MAPK1 P28482 2/20 0.43
TP53 P04637 1/20 0.43
MAT2A P31153 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
ALDH1A1 P00352 4/20 0.41
KDM4E B2RXH2 4/20 0.41
HPGD P15428 3/20 0.41
HSD17B10 Q99714 2/20 0.41
PIK3CB P42338 2/20 0.41
PIK3CD O00329 1/20 0.41
PIK3CA P42336 1/20 0.41
HTT P42858 4/20 0.40
LMNA P02545 4/20 0.40
ADORA3 P0DMS8 1/20 0.40
ADORA2A P29274 1/20 0.40
ALOX15 P16050 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8286461 0.93 PDE11A (0.47) PDE11AIGF1RMAPTMAPK1MAT2A
SCHEMBL8287408 0.90 PDE11A (0.44) PDE11AMAPTMAPK1MAT2AALDH1A1
SCHEMBL8287461 0.89 MAT2A (0.44) PDE11AMAPTMAPK1MAT2AL3MBTL1
SCHEMBL8287925 0.86 PDE11A (0.42) PDE11AMAPTMAPK1ALDH1A1HPGD
SCHEMBL8287935 0.85 NCF1 (0.43) PDE11AMAPTMAPK1ALDH1A1KDM4E
SCHEMBL8286539 0.84 PDE11A (0.42) PDE11AMAPTMAPK1L3MBTL1ALDH1A1
SCHEMBL8287402 0.82 PDE11A (0.39) PDE11AMAT2ALMNA
SCHEMBL8287910 0.82 MAPT (0.43) PDE11AMAPTMAPK1TP53L3MBTL1
SCHEMBL8287829 0.82 PDE11A (0.64) PDE11AIGF1RMAPTMAPK1TP53
SCHEMBL8286167 0.82 DRD2 (0.39) PDE11AMAPTMAPK1TP53ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed